On this page
Bexsero
Meningococcal Group B Vaccine
351(a) Standalone BLA
Overview
Source: Purple BookProprietary name
Bexsero
Proper name
Meningococcal Group B Vaccine
Licence type
351(a)
BLA number
125546
Applicant
GlaxoSmithKline Biologicals
Center
CBER
Presentations
1
First licensure
—
Presentations
Source: Purple Book| Strength | Dosage form | Route | Presentation | Status | Licensed |
|---|---|---|---|---|---|
| 0.5ML | Injection | Intramuscular | Pre-Filled Syringe | Rx | January 23, 2015 |
Sources for this page
| Purple Book | FDA | Licence type, presentations, reference product, exclusivity |